Andrew A. Hindman

Companies

• Theravance Biopharma, Inc.Chief financial officer Jun 7, 2019 to Nov 22, 2022¹
• Acorda TherapeuticsChief Business Dev. Officer May 15, 2014 to Mar 12, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TBTheravance Biopharma, Inc. TBPH384,714 shares³$6.6M at $17.03Nov 20, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 20, 2022Shares withheld for tax 25,057 shares at $10.85 of Theravance Biopharma, Inc.³
• Nov 18, 2022Sold 65,000 shares at $11.02 of Theravance Biopharma, Inc.³
• Aug 19, 2022Shares withheld for tax 25,676 shares at $9.34 of Theravance Biopharma, Inc.⁴
• Jul 25, 2022Granted 20,000 shares of Theravance Biopharma, Inc.⁵
• May 20, 2022Shares withheld for tax 3,365 shares at $8.74 of Theravance Biopharma, Inc.⁶
• Feb 18, 2022Shares withheld for tax 25,973 shares at $9.61 of Theravance Biopharma, Inc.⁷
• Dec 2, 2021Granted 340,000 shares of Theravance Biopharma, Inc.⁸
• Nov 19, 2021Shares withheld for tax 1,350 shares at $8.36 of Theravance Biopharma, Inc.⁹